
Semaglyn Resuable Pen
semaglutide
MRP
₹1,250
Offer Price
₹1,100
You Save
₹150 (12%)
Need availability, pricing or product information? Send us an inquiry.
Typically responds within 24 hours
Verified Product Information
Expert Assistance
Quick Inquiry Support
Introduction
The Semaglyn Reusable Pen is a reusable injection device developed by Cipla Ltd, designed for the administration of semaglutide using compatible cartridges. Also known as the semaglyn injector pen or semaglyn pen device, it is used to deliver precise doses of medication through subcutaneous injection. Semaglutide is a GLP-1 receptor agonist commonly prescribed for improving blood sugar control and supporting weight management. The Semaglutide pen for diabetes injection is widely used in adults with type 2 diabetes to help regulate blood glucose levels. At the same time, the semaglyn pen for weight loss injection supports appetite control and sustained weight reduction when combined with lifestyle changes. This makes the Semaglyn reusable pen a practical and user-friendly option for long-term therapy. It is important to note that the Semaglyn pen device does not contain medication by itself. It must be used with compatible semaglutide cartridges and appropriate pen needles. Your doctor will provide a personalised Semaglyn pen dosage guide based on your condition, treatment response, and goals. Patients should carefully follow Semaglyn pen injector instructions and understand how to
Uses
The Semasize Reusable Pro Pen is used to administer Semaglutide for: Weight management in adults with obesity. Weight management in overweight adults with at least one weight-related health condition. Supporting weight loss when combined with a reduced-calorie diet and increased physical activity.
How to Consume
To use the Semaglyn Reusable Pen Injector: Wash your hands thoroughly. Attach a new needle to the pen. Insert the Semanext cartridge containing Semaglutide into the pen. Set the prescribed dose as directed by your healthcare provider. Clean the injection site (thigh or abdomen) with an alcohol swab. Inject the medication subcutaneously as instructed. Remove and dispose of the needle safely after each use. Always follow the instructions provided by your healthcare provider or the device manual for proper usage.
Side Effects
Common Side Effects: Injection site reactions (pain, redness, swelling) Nausea Leg cramps Dizziness Serious Side Effects: Hypercalcemia (elevated calcium levels) Allergic reactions (rash, itching, swelling) Osteosarcoma (a rare type of bone cancer) If you experience any severe side effects, discontinue use and consult your healthcare provider immediately.
Safety Advice
- Pregnancy Unsafe The use of the Semaglyn Reusable Pen Injector for administering Semaglutide is unsafe during pregnancy. Consult your doctor before use. Breast Feeding Unsafe Semaglutide administration via the Semaglyn Reusable Pen Injector is unsafe while breastfeeding. Seek medical advice prior to use. Lungs Consult Your Doctor There is no known direct impact on lung function
- however, if you have pre-existing lung conditions, consult your healthcare provider. Liver Consult Your Doctor Limited data is available on the use of Semaglutide in patients with liver disease. Consult doctor before initiating therapy. Alcohol Unsafe Consumption of alcohol may interfere with bone health and the effectiveness of Semaglutide. Consult a doctor regarding alcohol use. Driving Consult Your Doctor If you experience dizziness or other side effects after injection, avoid driving or operating heavy machinery.
Storage
2 - 8°C
Need more information about this medicine?
Get pricing, availability and product assistance from our team.




